Discover 1,134 paid clinical trials in Norwalk, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,134
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
for
Idiopathic Pulmonary Fibrosis
Location: New York NY, Farmington CT, Philadelphia PA,
Sponsor: Cumberland Pharmaceuticals
Sex: All
Age: 40+
Code: NCT05571059
Phase 2, Recruiting
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Location: New York NY, Hartford CT, Philadelphia PA, Baltimore MD,
Sponsor: Endospan Ltd.
Sex: All
Age: 18+
Code: NCT04471909
Recruiting
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
for
Depressive Disorder, Treatment-Resistant
Location: New York NY, Cedarhurst NY, Farmington CT, Watertown MA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07716098
Phase 3, Recruiting
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
for
Major Depressive Disorder
Location: New York NY, Brooklyn NY, Farmington CT, Toms River NJ,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 18 - 65
Code: NCT05850689
Phase 3, Recruiting
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
for
Major Depressive Disorder (MDD)
Location: New York NY, Brooklyn NY, Cromwell CT, Marlton NJ,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70
Code: NCT07226661
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
for
Crohn Disease, Colitis, Ulcerative
Location: New York NY, Bristol CT, Charlottesville VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0+
Code: NCT06651281
Phase 3, Recruiting
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
for
Psychosis Associated With Alzheimer's Disease
Location: Woodmere NY, Farmington CT, Matthews NC, Atlanta GA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 55 - 70+
Code: NCT05980949
Phase 3, Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
for
Pain, Sickle Cell Disease
Location: New York NY, Newark NJ, Hartford CT, Rochester NY,
Sponsor: University of Pittsburgh
Sex: All
Age: 16 - 39
Code: NCT06374238
Recruiting
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
for
Early Stage Breast Cancer
Location: New York NY, Hartford CT
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female
Age: 21 - 70+
Code: NCT04458532
Recruiting
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients
for
Melanoma Stage III, Melanoma Stage IV
Location: New York NY, Hartford CT
Sponsor: Philogen S.p.A.
Sex: All
Age: 18+
Code: NCT06284590
Phase 2, Recruiting
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
for
Acute Leukemia, Newly Diagnosed, Relapsed
Location: New York NY, Hartford CT
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT02677064
Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: New York NY, Hartford CT, Newark DE, East Syracuse NY,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase 3, Recruiting
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Location: New York NY, Boston MA, Houston TX, Austin TX,
Sponsor: Avenzo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07193511
Phase 1, Phase 2, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations